The evolution and current state of bariatric endoscopy in Western countries

키워드

참고문헌 (85)

1. "Obesity and overweight" (2021)[URL]
2. Wharton S, "Interest, views and perceived barriers to bariatric surgery in patients with morbid obesity", Clin Obes, 6, pp.154~160 (2016)
3. ASGE, "ASMBS Task Force on Endoscopic Bariatric Therapy", A pathway to endoscopic bariatric thera pies, 2011, pp.74, 943~953
4. Stavrou G, "Six intragastric balloons : which to choose?", World J Gastrointest Endosc, 13, pp.238~259 (2021)
5. Gómez V, "Delayed gastric empty ing as a proposed mechanism of action during intragastric balloon therapy : results of a prospective study", Obesity(Silver Spring), 24, pp.1849~1853 (2016)
6. ASGE Bariatric Endoscopy Task Force and ASGE Technology Com mittee, "ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies", Gastro intest Endosc, 82, pp.425~438 (2015)
7. Kumar N, "The influence of the Orbera intragastric balloon filling volumes on weight loss, tolerability, and adverse events : a systematic review and meta-analysis", Obes Surg, 27, pp.2272~2278 (2017)
8. Sullivan S, "Randomized sham-controlled trial of the 6-month swallowable gas-filled intragastric balloon sys tem for weight loss", Surg Obes Relat Dis, 14, pp.1876~1889 (2018)
9. De Castro ML, "Efficacy, safety, and tolerance of two types of intragastric balloons placed in obese sub jects : a double-blind comparative study", Obes Surg, 20, pp.16421646~ (2010)
10. Abu Dayyeh BK, "Adjustable intragastric balloon for treatment of obesity : a multicentre, open-label, ran domised clinical trial", Lancet, 398, pp.1965~1973 (2021)
11. Vantanasiri K, "The efficacy and safety of a procedureless gastric balloon for weight loss : a systematic review and meta-analysis", Obes Surg, 30, pp.3341~3346 (2020)
12. Fittipaldi-Fernandez RJ, "Intragas tric balloon : a retrospective evaluation of 5874 patients on tolerance, complications, and efficacy in different degrees of overweight", Obes Surg, 30, pp.4892~4898 (2020)
13. Nunes GC, "Assessment of weight loss with the intragastric balloon in patients with different degrees of obesity", Surg Laparosc Endosc Percutan Tech, 27, pp.e83~e86 (2017)
14. Al-Sabah S, "Efficacy of intragastric bal loon for the management of obesity : experience from Kuwait", Surg Endosc, 30, pp.424~429 (2016)
15. Jamal MH, "The safety and efficacy of procedureless gastric balloon : a study examining the effect of elipse intragastric balloon safety, short and medium term effects on weight loss with 1-year follow-up post-removal", Obes Surg, 29, pp.12361241~ (2019)
16. Wiggins T, "Safety and efficacy of 12-month intra-gastric balloon-series of over 1100 patients", Obes Surg, 34, pp.176~182 (2024)
17. Genco A, "BioEnterics intragastric balloon : the Italian experience with 2, 515 patients", Obes Surg, 15, pp.11611164~ (2005)
18. Busetto L, "Obstructive sleep apnea syndrome in morbid obesity : effects of intragastric balloon", Chest, 128, pp.618~623 (2005)
19. Popov VB, "The impact of intragastric balloons on obesity-related co-morbidities : a systematic review and meta-analysis", Am J Gastroenterol, 112, pp.429~439 (2017)
20. Aoko O, "Meta-analysis : impact of intragastric balloon therapy on NAFLD-related parameters in patients with obesity", Aliment Pharmacol Ther, 59, pp.8~22 (2024)
21. Rinella ME, "A multisociety Delphi con sensus statement on new fatty liver disease nomenclature", Ann Hepatol, 29, pp.101133~ (2024)
22. Hedjoudje A, "Efficacy and safety of endoscopic sleeve gastroplasty : a systematic review and me ta-analysis", Clin Gastroenterol Hepatol, 18, pp.1043~1053 (2020)
23. Sharaiha RZ, "Endoscopic sleeve gastro plasty significantly reduces body mass index and metabolic compli cations in obese patients", Clin Gastroenterol Hepatol, 15, pp.504510~ (2017)
24. Nunes BC, "Impact of endoscopic sleeve gastroplasty in non-alcoholic fatty liver disease : a systematic review and meta-analysis", Obes Surg, 33, pp.2917~2926 (2023)
25. AlKhatry M, "Improvements in hepatic steatosis, obesity, and insulin resistance in adults with nonalcoholic fatty liver disease after the primary obesity surgery endoluminal 2. 0procedure", Endoscopy, 55, pp.1028~1034 (2023)
26. Thompson CC, "Percutaneous gastrostomy device for the treatment of class II and class III obe sity : results of a randomized controlled trial", Am J Gastroenterol, 112, pp.447~457 (2017)
27. Jirapinyo P, "Effect of aspiration therapy on obesity-related comorbidities : systematic review and me ta-analysis", Clin Endosc, 53, pp.686~697 (2020)
28. Jirapinyo P, "Effect of the duodenal-jejunal bypass liner on glycemic control in patients with type 2 diabetes with obesity : a meta-analysis with secondary analysis on weight loss and hormonal changes", Diabetes Care, 41, pp.1106~1115 (2018)
29. Roehlen N, "Impact of duodenal-jejunal bypass liner(DJBL)on NAFLD in patients with obesity and type 2diabetes mellitus", Nutrition, 103-104, pp.111806~ (2022)
30. de Oliveira GH, "Metabolic effects of endoscopic duodenal mucosal resurfacing : a systematic review and meta-analysis", Obes Surg, 31, pp.1304~1312 (2021)
31. van Baar AC, "Endoscopic duodenal mu cosal resurfacing improves glycaemic and hepatic indices in type 2diabetes : 6-month multicentre results", JHEP Rep, 1, pp.429~437 (2019)
32. Hadefi A, "Endoscopic duodenal mucosal resurfacing for nonalcoholic steatohepatitis(NASH) : a pilot study", Endosc Int Open, 9, pp.E1792~E1800 (2021)
33. Machytka E, "Partial jejunal diversion using an incisionless magnetic anastomosis system : 1-year interim results in patients with obesity and diabetes", Gastrointest Endosc, 86, pp.904~912 (2017)
34. Trang J, "Incidence of nausea and vomiting af ter intragastric balloon placement in bariatric patients : a systematic review and meta-analysis", Int J Surg, 57, pp.22~29 (2018)
35. Vargas EJ, "Changes in time of gastric emptying after surgical and endoscopic bariatrics and weight loss : a systematic review and meta-analysis", Clin Gastroenterol Hepatol, 18, pp.57~68 (2020)
36. Pontecorvi V, "Spontaneous intragastric bal loon hyperinflation is probably due to microbial overgrowth of the filling liquid", Obes Surg, 32, pp.1783~1785 (2022)
37. "UPDATE: Potential risks with liquid-filled intragastric balloons: letter to health care providers" (2020)[URL]
38. Neto MG, "Brazilian Intragastric Balloon Consensus Statement(BIBC) : practical guidelines based on experi ence of over 40, 000 cases", Surg Obes Relat Dis, 14, pp.151~159 (2018)
39. Dumonceau JM, "Evidence-based review of the Bioenterics intragas tric balloon for weight loss", Obes Surg, 18, pp.1611~1617 (2008)
40. Turan UF, "Factors of affecting the success of in tragastric balloon", Surg Laparosc Endosc Percutan Tech, 33, pp.141146~ (2023)
41. Tai CM, "Effectiveness of intragastric balloon treatment for obese patients : one-year follow-up after balloon re moval", Obes Surg, 23, pp.2068~2074 (2013)
42. Kotzampassi K, "Looking into the profile of those who succeed in losing weight with an intragastric balloon", J Laparoendosc Adv Surg Tech A, 24, pp.295~301 (2014)
43. Dogan UB, "Five percent weight lost in the first month of intragastric balloon treatment may be a predictor for long-term weight maintenance", Obes Surg, 23, pp.892~896 (2013)
44. Chan DL, "Outcomes with intra-gastric bal loon therapy in BMI < 35 non-morbid obesity : 10-year follow-up study of an RCT", Obes Surg, 31, pp.781~786 (2021)
45. Kotzampassi K, "500 intragastric balloons : what happens 5 years thereafter?", Obes Surg, 22, pp.896903~ (2012)
46. Huberty V, "Safety and feasibility of an endoluminal-suturing device for endoscopic gastric reduction(with video)", Gastrointest Endosc, 85, pp.833~837 (2017)
47. Lopez-Nava G, "Modified primary obesity surgery endoluminal(POSE-2)procedure for the treatment of obesity", VideoGIE, 5, pp.91~93 (2020)
48. Abu Dayyeh BK, "Endoscopic sleeve gastroplasty alters gastric physiology and induces loss of body weight in obese individuals", Clin Gastroenterol Hepatol, 15, pp.37~43 (2017)
49. Abu Dayyeh BK, "Endoscopic sleeve gastroplas ty : a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity", Gastrointest Endosc, 78, pp.530~535 (2013)
50. Bove V, "Common and uncommon prob lems during endoscopic suturing with Apollo overstitch : tips and tricks for troubleshooting", Tech Innov Gastrointest Endosc, 23, pp.220~225 (2021)
51. Abu Dayyeh BK, "Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity(MERIT) : a pro spective, multicentre, randomised trial", Lancet, 400, pp.441~451 (2022)
52. Sharaiha RZ, "Five-year outcomes of endoscopic sleeve gastroplasty for the treatment of obesity", Clin Gas troenterol Hepatol, 19, pp.1051~1057 (2021)
53. Lopez-Nava G, "Endoscopic sleeve gastro plasty(ESG)for morbid obesity : how effective is it?", Surg Endosc, 36, pp.352~360 (2022)
54. Gala K, "Performance of endoscopic sleeve gastroplasty by obesity class in the United States clinical set ting", Clin Transl Gastroenterol, 15, pp.e00647~ (2024)
55. Barrichello S, "Endoscopic sleeve gastroplasty in the management of over weight and obesity : an international multicenter study", Gastrointest Endosc, 90, pp.770~780 (2019)
56. Alqahtani A, "Short-term out comes of endoscopic sleeve gastroplasty in 1000 consecutive pa tients", Gastrointest Endosc, 89, pp.1132~1138 (2019)
57. Fehervari M, "Medium-term weight loss and remission of comorbidities following endoscopic sleeve gastroplasty : a systematic review and meta-analysis", Obes Surg, 33, pp.3527~3538 (2023)
58. Huberty V, "Endoscopic sutured gastroplasty in addition to lifestyle modification : short-term efficacy in a con trolled randomised trial", Gut, 70, pp.1479~1485 (2021)
59. Gkolfakis P, "Weight loss after endoscopic sleeve gastroplasty is independent of suture pattern : results from a randomized controlled trial", Endosc Int Open, 10, pp.E1245~E1253 (2022)
60. Sullivan S, "Randomized sham-con trolled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity : the ESSENTIAL trial", Obesity(Silver Spring), 25, pp.294~301 (2017)
61. Lopez Nava G, "Prospective multi center study of the primary obesity surgery endoluminal(POSE 2. 0)procedure for treatment of obesity", Clin Gastroenterol Hepatol, 21, pp.81~89 (2023)
62. Lopez-Nava G, "Safety and feasibility of a novel endoscopic suturing device(EndoZip TM)for treatment of obesity : first-in-human study", Obes Surg, 30, pp.1696~1703 (2020)
63. "Evaluation of health improve ment in obese patients with obesity-related comorbidities followed by EndoZip procedure (CL00010)" (2022)[URL]
64. "Evaluation of EndoZip system in obese patients who failed to reduce weight with non-surgical weight loss methods" (2021)[URL]
65. Storm AC, "Endoscopic sleeve gastroplasty for obe sity : defining the risk and reward after more than 1600 procedures", Gastrointest Endosc, 89, pp.1139~1140 (2019)
66. Neto MG, "Brazilian consensus on endoscopic sleeve gastroplasty", Obes Surg, 31, pp.70~78 (2021)
67. Alqahtani A, "Endoscopic sleeve gastroplasty in 109 consecutive children and adolescents with obe sity : two-year outcomes of a new modality", Am J Gastroenterol, 114, pp.1857~1862 (2019)
68. Matteo MV, "Outcomes of endoscopic sleeve gastroplasty in the elder population", Obes Surg, 32, pp.33903397~ (2022)
69. Lopez-Nava G, "Bariatric endoscopy procedure type or follow-up : what predicted success at 1 year in 962obese patients?", Endosc Int Open, 7, pp.E1691~E1698 (2019)
70. Salminen P, "IFSO consensus on definitions and clinical practice guidelines for obesity management : an Interna tional Delphi Study", Obes Surg, 34, pp.30~42 (2024)
71. Li R, "Endoscopic sleeve gastro plasty(ESG)for high-risk patients, high body mass index(> 50 kg", m2)patients, and contraindication to abdominal surgery, 2021, pp.31, 3400~3409
72. Fayad L, "Endoscopic sleeve gastroplasty versus intragastric balloon insertion : efficacy, durability, and safety", Endoscopy, 51, pp.532~539 (2019)
73. Singh S, "Intragastric balloon versus en doscopic sleeve gastroplasty for the treatment of obesity : a systematic review and meta-analysis", Obes Surg, 30, pp.3010~3029 (2020)
74. Sullivan S, "Aspiration therapy for obesity", Gastrointest Endosc Clin N Am, 27, pp.277~288 (2017)
75. "FDA approves Aspi reAssist obesity device" (2016)[URL]
76. Thompson CC, "Aspiration therapy for the treatment of obesity : 4-year results of a multicenter random ized controlled trial", Surg Obes Relat Dis, 15, pp.1348~1354 (2019)
77. "Aspire bariatrics company update" (2016)[URL]
78. Angelini G, "Small intesti nal metabolism is central to whole-body insulin resistance", Gut, 70, pp.1098~1109 (2021)
79. Rodriguez L, "Pilot clinical study of an endo scopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes", Diabetes Technol Ther, 11, pp.725~732 (2009)
80. Caiazzo R, "Efficacy and safety of the duodeno-jejunal bypass liner in patients with metabolic syndrome : a multicenter randomized controlled trial(ENDOMETAB)", Ann Surg, 272, pp.696~702 (2020)
81. Oh JH, "Proton pump inhibitor use increases pyogenic liver abscess risk : a nationwide cohort study", J Neurogas troenterol Motil, 27, pp.555~564 (2021)
82. "EndoBarrier System Pivotal Tri al(Rev E v2) (STEP-1)" (2023)[URL]
83. Mingrone G, "Safety and efficacy of hy drothermal duodenal mucosal resurfacing in patients with type 2 di abetes : the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial", Gut, 71, pp.254~264 (2022)
84. van Baar AC, "Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus : one year results from the first international, open-label, prospective, multicentre study", Gut, 69, pp.295~303 (2020)
85. Rajagopalan H, "Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes : 6-month interim analysis from the first-in-human proof-of-concept study", Diabetes Care, 39, pp.2254~2261 (2016)

관련 논문AI추천